J.P. Morgan Notebook: Thursday, January 16

17 Jan 2014

• By Paul Bonanos, Wendy Diller, and Stacy Lawrence

News and notes from the fourth and final day of the 2014 J.P. Morgan Healthcare Conference, including highlights from Furiex Pharmaceuticals’ late-stage pipeline, GSK’s latest DPU, newly public Intrexon, and angel-backed KemPharm.

J.P. Morgan Notebook: Thursday, January 16

More from United States

More from North America